PRFX: PainReform Corp Operatsion rentabellik

PainReform (PRFX) tovar belgisi

PainReform Ltd. og'riq qoldiruvchi vositalarni yetkazib berish tizimlarini yaratish uchun biopolimerlarga investitsiya kiritmoqda. GURU.Markets platformasida operatsion marjani tahlil qilib, -16629.00 parametrning joriy qiymati ekanligini ko'ramiz. Kompaniyaga tegishli texnologiya opioidlarni bartaraf etadi va qaramlik bilan bog'liq ijtimoiy muammolarni hal qiladi. Biznes dinamikasi klinik sinovlarning muvaffaqiyati va AQSh bozoriga chiqishga bog'liq bo'lib, makroiqtisodiy tebranishlardan mustaqil qolmoqda.

PRFX: painreform.com Sotuvning operatsion rentabelligi 04.07.2022 - 19.11.2026

painreform.com (PRFX) kompaniyasi koʻrsatkichlari kesimi va tahlili

Kompaniyaning fundamental baholanishi:PRFX, PainReform Corp
PainReform Ltd. asosiy tovari

Faol savdolarsiz klinik sinovlar bosqichida bo'lgan biotechnologiya kompaniyasi PainReform Ltd. (PRFX) uchun operatsion marja dori vositalarini ishlab chiqish xarajatlarini boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu operatsion marja grafigini tahlil qilish orqali investor operatsion foydaning tushumga nisbatini baholaydi, bu esa emitentning joriy narx belgilash imkoniyatlari yo'qligini hisobga olgan holda, mahsulot tijaratlashtirilishidan oldin kapitalning sarflanish tezligini kuzatish imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|TNF Pharmaceuticals - Operatsion foyda marjasi|Operatsion marja YCBD|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.